[1]于佳卉,毛光兰,王庆志,等.沉默信号调节蛋白6在溃疡性结肠炎小鼠结肠组织中的表达及意义[J].新乡医学院学报,2021,38(9):806-811.[doi:10.7683/xxyxyxb.2021.09.002]
 YU Jiahui,MAO Guanglan,WANG Qingzhi,et al.Expression and role of silent information regulator 6 in colon tissues of mice with ulcerative colitis[J].Journal of Xinxiang Medical University,2021,38(9):806-811.[doi:10.7683/xxyxyxb.2021.09.002]
点击复制

沉默信号调节蛋白6在溃疡性结肠炎小鼠结肠组织中的表达及意义
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
38
期数:
2021年9
页码:
806-811
栏目:
基础研究
出版日期:
2021-09-05

文章信息/Info

Title:
Expression and role of silent information regulator 6 in colon tissues of mice with ulcerative colitis
作者:
于佳卉1毛光兰2 王庆志1熊熙文1
(1.新乡医学院法医学院,河南 新乡 453003;2.新乡医学院第三附属医院康复科,河南 新乡 453003)
Author(s):
YU Jiahui1MAO Guanglan2WANG Qingzhi1XIONG Xiwen1
(1.School of Forensic Medicine,Xinxiang Medical University,Xinxiang 453003,Henan Province,China2.Department of Rehabilitation,the Third Affiliated Hospital of Xinxiang Medical University,Xinxiang 453003,Henan Province,China)
关键词:
沉默信号调节蛋白6溃疡性结肠炎葡聚糖硫酸钠黏膜损伤
Keywords:
silent information regulator 6ulcerative colitisdextran sulfate sodium saltmucosal injury
分类号:
R574.62
DOI:
10.7683/xxyxyxb.2021.09.002
文献标志码:
A
摘要:
目的 探讨沉默信号调节蛋白(SIRT)6在溃疡性结肠炎(UC)小鼠结肠组织中的表达及意义。方法 将22只14日龄清洁级无病原体C57BL6/J野生型(WT)小鼠分为WT对照组(n=6)和WT-葡聚糖硫酸钠(WT-DSS)组(n=16),将13只肠道上皮细胞敲除SIRT6基因(SIRT6IKO)小鼠分为SIRT6IKO 对照组(n=3)和SIRT6IKO-DSS组(n=10)。WT对照组和SIRT6IKO对照组小鼠给予正常蒸馏水喂养,WT-DSS组和SIRT6IKO-DSS组小鼠给予25 g·L-1 DSS间断性喂养(每日 5 mL,连续7 d,然后更换正常饮用水喂养14 d为1个循环,共3个循环)建立UC模型。每天称小鼠体质量,观察小鼠大便性状、肉眼血便,计算小鼠疾病活动度指数(DAI)评分。于造模第3个循环末,将各组小鼠采用颈椎脱臼法处死,取新鲜结肠组织,应用苏木精-伊红(HE)染色观察WT-DSS组和SIRT6IKO-DSS组小鼠结肠黏膜损伤的病理学变化并进行评分,Western blot法检测WT对照组,SIRT6IKO 对照组和WT-DSS组小鼠结肠组织中SIRT6蛋白表达来判断基因敲除效率,免疫组织化学法检测WT-DSS组和SIRT6IKO-DSS组小鼠结肠组织中巨噬细胞特异性标志物F4/80的表达,实时荧光定量聚合酶链反应法检测WT-DSS组和SIRT6IKO-DSS组小鼠结肠组织中白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)mRNA表达水平。结果 SIRT6IKO对照组小鼠结肠组织中SIRT6蛋白相对表达量显著高于WT对照组(P<0.05)。WT对照组小鼠结肠组织中SIRT6蛋白相对表达量显著高于WT-DSS组(P<0.05)。造模第3个循环末,WT-DSS组和SIRT6IKO-DSS组小鼠体质量均显著低于第1、2个循环末(P<0.05);2组小鼠造模第1循环末与第2个循环末体质量比较差异无统计学意义(P>0.05);造模第1、2个循环末,SIRT6IKO-DSS组与WT-DSS组小鼠体质量比较差异无统计学意义(P>0.05);造模第 3个循环末,SIRT6IKO-DSS组小鼠体质量显著低于WT-DSS组(P<0.05)。造模第3个循环末,WT-DSS组和SIRT6IKO-DSS组小鼠DAI评分均显著高于第1、2个循环末(P<0.05);WT-DSS组小鼠造模第2个循环末与第1个循环末DAI评分比较差异无统计学意义(P>0.05);造模第2个循环末,SIRT6IKO-DSS组小鼠DAI评分显著高于第1个循环末(P<0.05);造模第2、3个循环末,SIRT6IKO-DSS组小鼠DAI评分显著高于WT-DSS组(P<0.05)。SIRT6IKO-DSS组小鼠结肠组织组织学损伤指数显著低于WT-DSS组(P<0.05)。SIRT6IKO-DSS组小鼠结肠组织F4/80表达评分显著高于WT-DSS组(P<0.05)。SIRT6IKO-DSS组小鼠结肠组织中IL-6、TNF-α mRNA相对表达量显著高于WT-DSS组(P<0.05)。结论 UC小鼠结肠组织中SIRT6呈低表达,结肠组织中SIRT6缺失会加重结肠组织的炎症反应和损伤,增加UC易感性。
Abstract:
Objective To investigate the expression and role of silent information regulator 6 (SIRT6) in colon tissues of mice with ulcerative colitis(UC) and its significance.Methods Twenty-two 14-day-old pathogen free C57BL6/J wild-type (WT) mice were divided into WT control group and WT-dextran sulfate sodium salt(DSS) group,and 13 intestinal epithelial SIRT6 gene knockout (SIRT6IKO) mice were divided into SIRT6IKO control group and SIRT6IKO-DSS group.The mice in the WT-control group and SIRT6IKO control group were fed with normal distilled water,and the mice in the WT-DSS group and SIRT6IKO-DSS group were fed with 25 g·L-1 DSS(5 mL every day for 7 days,then normal drinking distilled water for 14 d,a total of three cycles) to establish the UC model.The body weight of mice was measured,the stool characteristics and gross bloody stool were observed on every dayand the disease activity index (DAI) was calculated.The mice in each group were killed by cervical dislocation and fresh colon tissue was collected at the end of the third cycle of modeling,hematoxylin-eosin (HE) staining was used to examine the pathological changes of colonic mucosal injury of mice in the WT-DSS group and SIRT6IKO-DSS group,and the pathological score was conductedthe expression of SIRT6 protein in colon tissue of mice in the WT control group,SIRT6IKO control group and WT-DSS group was detected by Western blot to determine gene knockout efficiencyimmunohis-tochemistry (IHC) was used to detect the expression of the macrophage specific marker F4/80 in the colon tissues of mice in the WT-DSS group and SIRT6IKO-DSS groupthe expression levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) mRNA in colon tissue of mice in the WT-DSS group and SIRT6IKO-DSS group were detected by real-time fluorescence quantitative polymerase chain reaction.Results The relative expression level of SIRT6 protein in colon tissue of mice in the SIRT6IKO control group was significantly higher than that in the WT control group (P<0.05).The relative expression of SIRT6 protein in colon tissue of mice in the WT control group was significantly higher than that in the WT-DSS group (P<0.05).At the end of the third cycle of modeling,the body weight of mice was significantly lower than that at the end of the first and the second cycle of modeling in the WT-DSS group and SIRT6IKO-DSS group (P<0.05)there was no significant difference in the body weight of mice at the end of the first cycle and the second cycle of modeling in the two groups (P>0.05).At the end of the first and the second cycles of modeling,there was no significant difference in body weight between WT-DSS group and SIRT6IKO-DSS group (P>0.05)at the end of the third cycle of modeling,the body weight of mice in the SIRT6IKO-DSS group was significantly lower than that in the WT-DSS group (P< 0.05).At the end of the third cycle of modeling,the DAI score of mice were significantly higher than that at the end of the first and the second cycle of modeling in the WT-DSS group and SIRT6IKO-DSS group (P<0.05)there was no significant difference in DAI score of mice between the end of the second cycle of modeling and the end of the first cycle of modeling in the WT-DSS group (P> 0.05)at the end of the second cycle of modeling,the DAI score of mice was significantly higher than that at the end of the first cycle in the SIRT6IKO-DSS group (P<0.05)at the end of the second and the third cycles of modeling,the DAI score of mice in the SIRT6IKO-DSS group was significantly higher than that in the WT-DSS group (P<0.05).The colonic histological injury index of mice in the SIRT6IKO-DSS group was significantly lower than that in the WT-DSS group (P<0.05).The F4/80 expression score in colon tissue of mice in the SIRT6IKO-DSS was significantly higher than that in the WT-DSS group (P<0.05).The expression levels of IL-6 and TNF-α mRNA in colon tissue of mice in the SIRT6IKO-DSS were significantly higher than those in the WT-DSS group (P<0.05).Conclusion The expression of SIRT6 in colon tissues of mice with UC is lower,the absence of SIRT6 in colonic tissue can aggravate the inflammatory response and colonic tissue injury,and increase the susceptibility of UC.

参考文献/References:

[1] OI C J,HILMI I,BANERJEE R,et al.Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn′s disease in Asia[J].J Gastroenterol Hepatol,2019,34(8):1296-1315.
[2] NG S C,SHI H Y,HAMIDA N,et al.Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century:a systematic review of population-based studies[J].Lancet,2017,90(10114):2769-2778.
[3] WEHKAMP J,GTZ M,HERRLINGER K,et al.Inflammatory bowel disease[J].Dtsch Arztebl Int,2016,113(5):72-82.
[4] MENDES K L,LELIS D F,SANTOS S H S.Nuclear sirtuins and inflammatory signaling pathways[J].Cytokine Growth Factor Rev,2017,38:98-105.
[5] TASSELLI L,ZHENG W,CHUA K F.SIRT6:novel mechanisms and links to aging and disease[J].Trends Endocrinol Metab,2017,28(3):168-185.
[6] MEI Z,ZHANG X,YI J,et al.Sirtuins in metabolism,DNA repair and cancer[J].J Exp Clin Cancer Res,2016,35(1):182.
[7] WELLMAN A S,METUKURI M R,KAZGAN N,et al.Intestinal epithelial sirtuin 1 regulates intestinal inflammation during aging in mice by altering the intestinal microbiota[J].Gastroenterology,2017,153(3):772-786.
[8] LIU F,BU H F,GENG H,et al.Sirtuin-6 preserves R-spondin-1 expression and increases resistance of intestinal epithelium to injury in mice[J].Mol Med,2017,23:272-284.
[9] COSNES J,GOWER-ROUSSEAU C,SEKSIK P,et al.Epidemiology and natural history of inflammatory bowel diseases[J].Gastroenterology,2011,140(6):1785-1794.
[10] SELVARATNAM S,GULLINO S,SHIM L,et al.Epidemiology of inflammatory bowel disease in South America:a systematic review[J].World J Gastroenterol,2019,25(47):6866-6875.
[11] SEEMANN S,ZOHLES F,LUPP A.Comprehensive comparison of three different animal models for systemic inflammation[J].J Biomed Sci,2017,24(1):60.
[12] ACTIS G C,PELLICANO R,FAGOONEE S,et al.History of inflammatory bowel diseases[J].J Clin Med,2019,8(11):1970.
[13] ALREHEILI K M,ALSALEEM K A,ALMEHAIDIB A I.Natural history and outcome of inflammatory bowel diseases in children in Saudi Arabia:a single-center experience[J].Saudi J Gastroenterol,2018,24(3):171-176.
[14] RYBAKOVSKY E,BULEZA N B,HOXHA K,et al.Spontaneous and cytokine-induced hole formation in epithelial cell layers:implications for barrier function studies with the gingival cell culture,Gie-3B11,and other epithelial models[J].Trends Cell Mol Biol,2018,13:99-114.
[15] KHAN D,SARIKHANI M,DASGUPTA S,et al.SIRT6 deacetylase transcriptionally regulates glucose metabolism in heart[J].J Cell Physiol,2018,233(7):5478-5489.
[16] YOU W,ROTILI D,LI T M,et al.Structural basis of sirtuin 6 activation by synthetic small molecules[J].Angew Chem Int Ed Engl,2017,56(4):1007-1011.
[17] BALESTRIERI M L,RIZZO M R,BARBIERI M,et al.Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques:effects of incretin treatment[J].Diabetes,2015,64(4):1395-1406.
[18] MOSTOSLAVSKY R,CHUA K F,LOMBARD D B,et al.Geno-mic instability and aging-like phenotype in the absence of mammalian SIRT6[J].Cell,2006,124(2):315-329.
[19] MARTINI E,KRUG S M,SIEGMUND B,et al.Mend your fences:the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease[J].Cell Mol Gastroenterol Hepatol,2017,4(1):33-46.
[20] FAN S,WEIGHT C M,LUISSINT A C,et al.Role of JAM-A tyrosine phosphorylation in epithelial barrier dysfunction during intestinal inflammation[J].Mol Biol Cell,2019,30(5):566- 578.
[21] TIAN T,WANG Z,ZHANG J.Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies[J].Oxid Med Cell Longev,2017,2017:4535194.
[22] SINGH U P,SINGH N P,MURPHY E,et al.Chemokine and cytokine levels in inflammatory bowel disease patients[J].Cytokine,2016,77:44-49.
[23] MELIA J M P,LIN R,XAVIER R J,et al.Induction of the metal transporter ZIP8 by interferon gamma in intestinal epithelial cells:potential role of metal dyshomeostasis in Crohn′s disease[J].Biochem Biophys Res Commun,2019,515(2):325-331.
[24] PENG X,LI J,TAN S,et al.COX-1/PGE2/EP4 alleviates mucosal injury by upregulating beta-arr1-mediated Akt signaling in colitis[J].Sci Rep,2017,7(1):1055.
[25] LI Y,LI X,COLE A,et al.Icariin improves Fanconi anemia hematopoietic stem cell function through SIRT6-mediated NF-kappa B inhibition[J].Cell Cycle,2018,17(3):367-376.

相似文献/References:

[1]侯再恩.肠炎平治疗溃疡性结肠炎58例[J].新乡医学院学报,2003,(05):376.
[2]侯再恩.肠炎平治疗溃疡性结肠炎58 例[J].新乡医学院学报,2003,(05):376.
[3]张小毅,刘瑞丽,韩效林,等.愈疡液治疗大鼠溃疡性结肠炎的实验研究[J].新乡医学院学报,2003,(01):021.
[4]张小毅,刘瑞丽,韩效林,等.愈疡液治疗大鼠溃疡性结肠炎的实验研究[J].新乡医学院学报,2003,(01):021.
[5]柯贤胜.美沙拉嗪对溃疡性结肠炎患者血清白细胞介素-6、白细胞介素-8及肿瘤坏死因子-α的影响 [J].新乡医学院学报,2012,(12):950.
[6]赵嘉莉1,张慧敏2.枯草杆菌二联活菌肠溶胶囊治疗溃疡性结肠炎疗效观察[J].新乡医学院学报,2016,(11):983.[doi:10.7683/xxyxyxb.2016.11.013]
[7]张 伟,杨银利,张 林,等.青柏溃结汤灌肠对溃疡性结肠炎大肠湿热证患者结肠黏膜愈合及血清炎性因子水平的影响[J].新乡医学院学报,2018,35(6):474.[doi:10.7683/xxyxyxb.2018.06.006.]
 ZHANG Wei,YANG Yin-li,ZHANG Lin,et al.Effect of Qingbaikuijietang enema on colonic mucosa healing and serum inflammatory factors in patients with ulcerative colitis and large intestine damp-heat syndrome[J].Journal of Xinxiang Medical University,2018,35(9):474.[doi:10.7683/xxyxyxb.2018.06.006.]
[8]杜鹏程,韩 璠,谷九莲.溃疡性结肠炎患者血清单核细胞趋化蛋白-1、高迁移率族蛋白B1、肿瘤坏死因子-α、白细胞介素-6和白细胞介素-10水平与肠道菌群的相关性[J].新乡医学院学报,2021,38(4):370.[doi:10.7683/xxyxyxb.2021.04.016]
 DU Pengcheng,HAN Fan,GU Jiulian.Correlation between serum monocyte chemoattractant protein-1,high mobility group protein B1,tumor necrosis factor-α,interleukin-6,interleukin-10 levels and intestinal flora in patients with ulcera-tive colitis[J].Journal of Xinxiang Medical University,2021,38(9):370.[doi:10.7683/xxyxyxb.2021.04.016]
[9]胡景岚.ω-3多不饱和脂肪酸和美沙拉嗪联合治疗对溃疡性结肠炎患者血清辅助性T细胞1及辅助性T细胞2细胞因子水平的影响[J].新乡医学院学报,2019,36(1):067.[doi:10.7683/xxyxyxb.2019.01.014.]
 HU Jing-lan.Effect of ω-3 polyunsaturated fatty acid combined with mesalazine on the levels of serum helper T cell 1 and helper T cell 2 cytokines in patients with ulcerative colitis[J].Journal of Xinxiang Medical University,2019,36(9):067.[doi:10.7683/xxyxyxb.2019.01.014.]
[10]朱佳丽,鲁素彩.小檗碱治疗溃疡性结肠炎研究进展[J].新乡医学院学报,2022,39(2):187.[doi:10.7683/xxyxyxb.2022.02.018]
 ZHU Jiali,LU Sucai.Research progress of berberine in the treatment of ulcerative colitis[J].Journal of Xinxiang Medical University,2022,39(9):187.[doi:10.7683/xxyxyxb.2022.02.018]

更新日期/Last Update: 2021-09-05